HeXun Biosciences Co (ROCO:6986) EV-to-FCF: (As of Jul. 12, 2026)


ROCO:6986 HeXun Biosciences Co Ltd ROCO:6986
23 GF Score
Price NT$47.00
! 1 Warning Sign
View Full Analysis

What is HeXun Biosciences Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, HeXun Biosciences Co's Enterprise Value is NT$1,977.2 Mil. HeXun Biosciences Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.0 Mil. Therefore, HeXun Biosciences Co's EV-to-FCF for today is .

The historical rank and industry rank for HeXun Biosciences Co's EV-to-FCF or its related term are showing as below:

ROCO:6986' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 14.64
Current: 14.64

During the past 6 years, the highest EV-to-FCF of HeXun Biosciences Co was 14.64. The lowest was 0.00. And the median was 0.00.

ROCO:6986's EV-to-FCF is ranked better than
52.28% of 329 companies
in the Biotechnology industry
Industry Median: 15.85 vs ROCO:6986: 14.64

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-12), HeXun Biosciences Co's stock price is NT$47.00. HeXun Biosciences Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1.090. Therefore, HeXun Biosciences Co's PE Ratio (TTM) for today is 43.12.


HeXun Biosciences Co  (ROCO:6986) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

HeXun Biosciences Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=47.00/1.090
=43.12

HeXun Biosciences Co's share price for today is NT$47.00.
HeXun Biosciences Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.090.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


HeXun Biosciences Co EV-to-FCF Related Terms


HeXun Biosciences Co EV-to-FCF Historical Data

* Premium members only.

The historical data trend for HeXun Biosciences Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeXun Biosciences Co EV-to-FCF Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial 0.00 0.00 134.19 32.54 20.97

HeXun Biosciences Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 32.54 0.00 0.00 20.97

ROCO:6986 vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, HeXun Biosciences Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeXun Biosciences Co EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where HeXun Biosciences Co's EV-to-FCF falls into.


ROCO:6986
23GF Score
HeXun Biosciences Co Ltd ROCO:6986
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeXun Biosciences Co EV-to-FCF Calculation

HeXun Biosciences Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1977.248/0
=

HeXun Biosciences Co's current Enterprise Value is NT$1,977.2 Mil.
HeXun Biosciences Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeXun Biosciences Co Business Description

Address Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.
23GF Score

Get the complete analysis for ROCO:6986

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$47.00
Price